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Abstract
Background: Because of the lack of reproducible brainstem ischemia models in rodents, the temporal profile of
ischemic lesions in the brainstem after transient brainstem ischemia has not been evaluated intensively. Previously,
we produced a reproducible brainstem ischemia model of Mongolian gerbils. Here, we showed the temporal
profile of ischemic lesions after transient brainstem ischemia.
Results: Brainstem ischemia was produced by occlusion of the bilateral vertebral arteries just before their entry
into the transverse foramina of the cervical vertebrae of Mongolian gerbils. Animals were subjected to brainstem
ischemia for 15 min, and then reperfused for 0 d (just after ischemia), 1 d, 3 d and 7 d (n = 4 in each group).
Sham-operated animals (n = 4) were used as control. After deep anesthesia, the gerbils were perfused with fixative
for immunohistochemical investigation. Ischemic lesions were detected by immunostaining for microtubule-
associated protein 2 (MAP2). Just after 15-min brainstem ischemia, ischemic lesions were detected in the lateral
vestibular nucleus and the ventral part of the spinal trigeminal nucleus, and these ischemic lesions disappeared
one day after reperfusion in all animals examined. However, 3 days and 7 days after reperfusion, ischemic lesions
appeared again and clusters of ionized calcium-binding adapter molecule-1(IBA-1)-positive cells were detected in
the same areas in all animals.
Conclusion: These results suggest that delayed neuronal cell death took place in the brainstem after transient
brainstem ischemia in gerbils.
Background
In the central nervous system, certain areas are selec-
tively damaged even after a brief ischemic insult, and
this topographical heterogeneity is known as “selective
vulnerability of the brain”. Hippocampal CA1 and neo-
cortical III, V, and VI are extremely vulnerable to ische-
mia and hypoxia [1]. The mechanism responsible for
this vulnerability is of particular importance to establish
therapeutic procedures, because elucidation of the
mechanism may lead to the development of novel ther-
apy to ameliorate ischemic damage.
Pathologic aspects and the topographic distribution of
ischemic lesions after transient ischemia have been
extensively studied in the rodent forebrain [2,3]. How-
ever, little is known about the distribution of ischemic
lesions after transient brainstem ischemia because of the
lack of reproducible brainstem ischemia models in
rodents. Previously, we established a brainstem ischemia
model in gerbils by occlusion of the bilateral vertebral
arteries, and demonstrated selective vulnerability after
permanent brainstem ischemia [4]. This gerbil model
has the following advantages: (1) it produces brainstem
ischemia without intracranial injury, (2) it produces
severe, reproducible brainstem ischemia, and (3) it
allows reperfusion.
In the present study, using this animal model, we
investigated the temporal profile of ischemic lesions in
the brainstem after transient brainstem ischemia in ger-
bils. We demonstrated ischemic lesions by immunos-
taining for microtubule-associated protein 2 (MAP2) in
the lateral vestibular nucleus and the ventral part of the
spinal trigeminal nucleus three days after transient
brainstem ischemia, while these ischemic lesions were
not found one day after ischemia. This delayed neuronal
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neuronal cell death in the hippocampus after transient
forebrain ischemia [5].
Methods
Animals and surgical procedure
Adult 12-16 week-old male Mongolian gerbils, weighing
60-80 g, were used in this study. All experiments were
approved by the Ethics Committee of Ehime University
Graduate School of Medicine and were conducted
according to the Guidelines for Animal Experimentation
at Ehime University Graduate School of Medicine. The
gerbils were housed in an animal room with a tempera-
ture of 21 to 23°C and a 12-hour light/dark cycle (light
on: 7 a.m. to 7 p.m.). The animals were allowed free
access to food and water until the end of the
experiment.
The gerbils were randomly divided into four groups,
which were subjected to brainstem ischemia for 15 min
and reperfused for 0 d (just after ischemia), 1 d, 3 d and
7 d (n = 4 in each group). Sham-operated animals (n =
4) were used as control. Animals were anesthetized with
1% halothane in 70% N2O and 30% O2.A n e s t h e t i z e d
animals were orotracheally intubated with a ventilation
tube. To facilitate access to the vertebral arteries, ani-
mals were placed in the supine position on a table tilted
at approximately 30° to the horizontal. An anterior mid-
line cervical incision was made, and the musculi longus
colli were dissected to expose the vertebral arteries just
before their entry into the transverse foramina of the
cervical vertebrae. Both vertebral arteries were looped
with 4-0 silk sutures. Then, the suture around each ver-
tebral artery was pulled by a 5-g weight to occlude the
circulation for 15 min. Consequently, apnea was
observed within 1 min after occlusion, and subsequent
convulsions were observed in all four limbs for about 1
min. After convulsions had ceased, all animals became
unresponsive and lost their corneal reflex. Mechanical
ventilation was initiated immediately after apnea was eli-
cited during ischemia. The tidal volume was set to 1 ml
and the rate was set to 70 breaths per minute. After 15
min of ischemia, the sutures were cut and removed to
allow recirculation, which was confirmed by visual
observation through an operating microscope. Within
10 min after reperfusion, spontaneous breathing reap-
peared and mechanical ventilation was ceased within 15
min after reperfusion.
Rectal temperature was maintained between 36.5 and
37.0°C by a heating lamp and a heating pad connected
to a thermistor (ATB-1100, Nihon Koden, Tokyo, Japan)
during surgery and until 1 h after reperfusion. After
resuscitation, the animals were maintained in an air-
conditioned room at about 22°C.
Histological procedures
After deep anesthesia with a lethal dose of sodium
pentobarbital (0.1 g/kg), the gerbils were perfused
with 4% paraformaldehyde in 0.1 M phosphate buffer
(pH 7.4) and the brain was dissected out. After fixa-
tion with the same fixative for overnight the brain
was dehydrated and embedded in paraffin. To investi-
gate the temporal profile of ischemic lesions in the
brainstem, we performed immunostaining for MAP2,
IBA-1 and GFAP at the level of the lateral vestibular
nucleus in the brainstem (5.5 mm caudal to the
bregma) since this area has been reported to be most
vulnerable to ischemia [4]. Coronal 5-μm-thick sec-
tions were examined by immunostaining for microtu-
bule-associated protein 2 (MAP2), IBA-1 and glial
fibrillary acidic protein (GFAP). Sections were immu-
nostained using a Vectastain ABC Elite Kit (Vector
Laboratories; Burlingame, Calif) with polyclonal anti-
MAP2 (donated by Dr. Niinobe, Osaka University),
polyclonal anti-IBA-1 (019-19741, Wako, Osaka,
Japan) or monoclonal anti-GFAP (G9369, Sigma, St.
Louis, USA) antibodies. Endogenous peroxidase in
deparaffinized tissue sections was blocked for 10 min-
utes with 3% H2O2 in deionized water, followed by
blocking with 10% goat serum diluted in 0.2% Tween-
20 in phosphate buffered saline at room temperature
for 1 hour. The tissues were then incubated with pri-
mary antibody (anti-MAP2, 1:1000; anti-IBA-1, 1:500;
anti-GFAP, 1:500) at 4°C overnight. Tissue sections
were washed and incubated with secondary antibody
(1:1000) for 1 hour at room temperature. After wash-
ing, sections were incubated with ABC complex for
30 minutes at room temperature, and then stained
with the chromogenic substrate 3, 3-diaminobenzidine
tetrahydrochloride (DAB) and H2O2,u n t i lo p t i m a l
staining was obtained.
Measurement of ischemic lesions
MAP2-stained sections were analyzed and images were
viewed using a microscope (ECLIPSE E800, Nikon,
Tokyo, Japan). The ischemic lesions detected by the loss
of immunoreaction for MAP2 were measured and quan-
tification was performed on images using ImageJ soft-
ware (National Institutes of Health, Bethesda, MD).
Statistics
All values are given as mean ± SD. Statistical analysis
was performed with the Statistical Package for the
Social Sciences, release 15 (SPSS ver. 15). Differences
were analyzed using one-way ANOVA followed by Bon-
ferroni’s multiple comparison test. A p value of less
than 0.05 was considered to indicate statistical
significance.
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Immunohistochemical investigation
Four gerbils each were used for the reperfusion periods
of 0, 1 d, and 3 d. As for the reperfusion period of 7 d,
we evaluated three animals because one animal died of
respiratory failure 5 days after ischemia. Sham-operated
animals (n = 4) were used as control. Loss of immunor-
eaction for MAP2 in neuropils, nerve cell bodies, and
dendrites was used as the criterion for the presence of
ischemic lesions. The findings were compared with
those in sham-operated controls. Each brain section was
examined by two investigators; and whenever there was
any uncertainty, a third investigator examined the speci-
men without any prior information.
Just after brainstem ischemia
Ischemic lesions detected by immunostaining for MAP2
were found in the lateral vestibular nucleus (LVe; blue
arrows in Figure 1B) and the ventral part of the spinal
trigeminal nucleus (Sp5; red arrows in Figure 1B) in all
4 animals (100%). Higher magnification photomicro-
graphs of ischemic lesions showed loss of immunoreac-
tion for MAP2 in neuropils and nerve cell bodies in
LVe (blue arrows in Figure 2B) and the ventral part of
Sp5 (red arrows in Figure 3B). Compared with sham-
operated controls, there was no change in IBA-1 (a mar-
ker of microglia and monocytic lineage) and GFAP (a
marker of astrocytes) expression (Figure 1G and 1L).
One day after brainstem ischemia
No ischemic lesion was detected by MAP2 staining (Fig-
ure 1C). Furthermore, there was no change in IBA-1
and GFAP expression, compared with that in sham-
operated controls (Figure 1H and 1M).
Three days after brainstem ischemia
Ischemic lesions in LVe (blue arrows in Figures 1D and
2D) and the ventral part of Sp5 (red arrows in Figures
1D and 3D) appeared again in all 4 animals (100%).
Compared with the ischemic lesions just after brainstem
ischemia, ischemic lesions in LV expanded ventrally to
include the spinal vestibular nucleus (SpVe) in 2 out of
4 animals (50%). De novo ischemic lesions were
detected in the dorsal part of Sp5 (blue arrowheads in
Figures 1D and 3D) and ventral cochlear nucleus (VC)
(red arrowheads in Figures1D and 4D) in 2 out of 4 ani-
mals (50%).
In addition, IBA-1 immunoreactivity was markedly up-
regulated in the central part of the ischemic lesions
where MAP2 immunostaining was lost. Up-regulation of
IBA-1 immunoreactivity was detected in LVe (blue
arrows in Figures 1I and 2I) and the ventral part of Sp5
(red arrows in Figures 1I and 3I) in 3 out of 4 animals
(75%). Up-regulation of IBA-1 immunoreactivity was
also detected in the dorsal part of Sp5 (blue arrowheads
in Figures 1I and 3I) and ventral cochlear nucleus (VC)
(red arrowheads in Figures 1I and 4I) in 2 out of 4 ani-
mals (50%). Higher magnification photomicrographs
demonstrated strongly IBA-1-positive cells in these
areas. These IBA-1-positive cells displayed an amoeboid
shape including only small perisomal lamellopodial
expansions or a few unbranched processes. They were
morphologically easily distinguishable from ramified
microglial cells, which were recognized by their thick
processes and large cell bodies.
Furthermore, immunoreactivity for GFAP disappeared
in ischemic lesions where immunostaining for MAP2 was
lost, whereas immunoreactivity for GFAP increased in
the neighboring areas around ischemic lesions. A reduc-
tion of GFAP staining was detected in LVe (blue arrows
in Figures 1N and 2N) and the ventral part of Sp5 (red
arrows in Figures 1N and 3N) in 3 out of 4 animals
(75%). A reduction of GFAP staining was also detected in
the dorsal part of Sp5 (blue arrowheads in Figures 1N
and 3N) and the ventral cochlear nucleus (VC) (red
arrowheads in Figures 1N and 4N) in 2 out of 4 animals
(50%). Higher magnification photomicrographs showed
that GFAP-positive astrocytes were not observed in
ischemic lesions where immunostaining for MAP2 was
lost. Reactive astrocytes with thick, long GFAP-positive
processes were distributed around ischemic lesions.
Seven days after brainstem ischemia
Ischemic lesions detected by immunostaining for MAP2
expanded further (Figure 5A-D). Ischemic lesions in
LVe (blue arrows in Figures 1E and 2E) and the ventral
part of Sp5 (red arrows in Figures 1E and 3E) appeared
in all 3 animals (100%). Ischemic lesions were also
detected in the dorsal part of Sp5 (blue arrowheads in
Figures 1E and 3E) and the ventral cochlear nucleus
(VC) (red arrowheads in Figures 1E and 4E) in 1 out of
3 animals (33%).
IBA-1 immunoreactivity was markedly up-regulated in
ischemic lesions where MAP2 immunostaining was lost.
Compared with the profile of IBA-1 staining three days
after brainstem ischemia, strongly IBA-1-positive cells
with an amoeboid shape were distributed more periph-
erally in ischemic lesions as well as in the center of
ischemic lesions. Up-regulation of IBA-1 immunoreac-
tivity was detected in LVe (blue arrows in Figures 1J
and 2J) and the ventral part of Sp5 (red arrows in Fig-
ures 1J and 3J) in all three animals (100%). Up-regula-
tion of IBA-1 immunoreactivity was also detected in the
dorsal part of Sp5 (blue arrowheads in Figures 1J and
3J) and ventral cochlear nucleus (VC) (red arrowheads
in Figures 1J and 4J) in one out of three animals (33%).
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Page 3 of 11Figure 1 Representative photomicrographs of immunostaining after transient brainstem ischemia for 15 min (pons). Left column shows
immunoreactivity for MAP2 (A-E); middle column shows immunoreactivity for IBA-1 (F-J); right column shows immunoreactivity for GFAP (K-O).
Ischemic lesions with loss of MAP2 staining were detected in the lateral vestibular nucleus (LVe: B; blue arrows) and the ventral part of the spinal
trigeminal nucleus (Sp5: B; red arrows) after bilateral vertebral artery occlusion (BVO) for 15 min. These ischemic lesions had disappeared at 1 day
after reperfusion (C). At 3 days and 7 days after reperfusion, ischemic lesions appeared again and expanded further (D and E; blue and red
arrows). New ischemic lesions were detected in the dorsal part of Sp5 (D and E; blue arrowheads) and ventral cochlear nucleus (VC) (D and E;
red arrowheads). At the same time, clusters of amoeboid microglia/macrophages were detected in the same areas (I and J; blue and red arrows/
arrowheads). At 3 days and 7 days after reperfusion, immunoreactivity for GFAP was lost in the ischemic lesions, and increased immunoreactivity
for GFAP was detected around ischemic lesions (N and O; blue and red arrows/arrowheads). Scale bar = 1 mm.
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Page 4 of 11Figure 2 Representative photomicrographs of immunostaining after transient brainstem ischemia for 15 min (vestibular nucleus). Left
column shows immunoreactivity for MAP2 (A-E); middle column shows immunoreactivity for IBA-1 (F-J); right column shows immunoreactivity
for GFAP (K-O). Ischemic lesions with loss of immunoreactivity for MAP2 were seen in the lateral vestibular nucleus after bilateral vertebral artery
occlusion (BVO) for 15 min (B; blue arrows), and these lesions had disappeared at 1 day after reperfusion (C). However, ischemic lesions had
reappeared and expanded further at 3 days and 7 days after reperfusion (D and E; blue arrows). Clusters of IBA-1-positive amoeboid microglia/
macrophages (I and J; blue arrows) and loss of expression of GFAP (N and O; blue arrows) were detected in the same areas where MAP2
expression was markedly lost at 3 days and 7 days after reperfusion. Increased immunoreactivity for GFAP (N and O; blue arrows) was also
detected around ischemic lesions at 3 days and 7 days after reperfusion. Scale bars = 0.5 mm.
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Page 5 of 11Figure 3 Representative photomicrographs of immunostaining after transient brainstem ischemia for 15 min (spinal trigeminal
nucleus). Left column shows immunoreactivity for MAP2 (A-E); middle column shows immunoreactivity for IBA-1 (F-J); right column shows
immunoreactivity for GFAP (K-O). Ischemic lesions with loss of immunoreactivity for MAP2 were seen in the ventral part of Sp5 after bilateral
vertebral artery occlusion (BVO) for 15 min (B; red arrows), and these lesions had disappeared at 1 day after reperfusion (C). However, ischemic
lesions had reappeared and expanded further (D and E; red arrows) and new ischemic lesions were detected in the dorsal part of Sp5 (D and E;
blue arrowheads) at 3 days and 7 days after reperfusion. Clusters of IBA-1-positive amoeboid microglia/macrophages (I and J; red arrows and
blue arrowheads) and loss of GFAP expression (N and O; red arrows and blue arrowheads) were detected in the same areas where MAP2
expression was lost at 3 days and 7 days after reperfusion. Increased immunoreactivity for GFAP (N and O; red arrows and blue arrowheads) was
also detected around ischemic lesions at 3 days and 7 days after reperfusion. Scale bars = 0.5 mm.
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Page 6 of 11Figure 4 Representative photomicrographs of immunostaining after transient brainstem ischemia for 15 min (cochlear nucleus).L e f t
column shows immunoreactivity for MAP2 (A-E); middle column shows immunoreactivity for IBA-1 (F-J); right column shows immunoreactivity
for GFAP (K-O). Ischemic lesions with loss of immunoreactivity for MAP2 were seen in the ventral cochlear nucleus (VC) at 3 days and 7 days
after reperfusion (D and E; red arrowheads). Clusters of IBA-1-positive amoeboid microglia/macrophages (I and J; red arrowheads) and loss of
GFAP expression (N and O; red arrowheads) were detected in the same areas where MAP2 expression was lost at 3 days and 7 days after
reperfusion. Increased immunoreactivity for GFAP (N and O; red arrowheads) was also detected around ischemic lesions at 3 days and 7 days
after reperfusion. Scale bars = 0.5 mm.
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part of ischemic lesions where MAP2 immunostaining
was lost. Immunoreactivity for GFAP increased in the
periphery of ischemic lesions as well as the neighboring
areas around ischemic lesions. These results suggested
that reactive astrocytes proliferated in the neighboring
areas around ischemic lesions and migrated into the
ischemic lesions. A reduction of GFAP staining was
detected in LVe (blue arrows in Figures 1O and 2O)
and the ventral part of Sp5 (red arrows in Figures 1O
and 3O) in all 3 animals (100%). A reduction of GFAP
staining was also detected in the dorsal part of Sp5
(blue arrowheads in Figures 1O and 3O) and the ventral
cochlear nucleus (VC) (red arrowheads in Figures 1O
and 4O) in 1 out of 3 animals (33%).
Temporal profile of ischemic lesions
The total area of ischemic lesions detected by MAP2
staining in each animal was calculated and summarized
in Figure 6. Just after brainstem ischemia for 15 min,
the total area of ischemic lesions was 0.33 ± 0.041
[Mean ± SD] (mm
2). Although ischemic lesions disap-
peared one day after brainstem ischemia, evolution of
ischemic lesions was detected 3 and 7 days after
Figure 5 Incidence maps of immunoreactivity for MAP2 (decrease) and IBA-1(increase) in coronal gerbil brain sections at various
times after transient brainstem ischemia for 15 min (at level of pons [5.5 mm caudal to bregma]). Areas of altered immunoreactivity
were outlined in all animals examined and superimposed to represent the incidence map (%). For details, see text.
Figure 6 Temporal profile of ischemic lesions detected by
MAP2 staining after transient brainstem ischemia for 15 min.
The area of ischemic lesions detected by MAP2 staining in each
animal was calculated. For details, see text. C: control, 0 d: just after
brainstem ischemia for 15 min, 1 d, 3 d and 7 d: 1, 3 and 7 days
after transient brainstem ischemia for 15 min, respectively. All values
are given as mean ± SD. Differences were analyzed using one-way
ANOVA followed by Bonferroni’s multiple comparison test. A p value
of less than 0.05 was considered to indicate statistical significance.
** and $$ indicate significant (p < 0.01) difference vs. C and 0 d,
respectively. $ indicates significant (p < 0.05) difference vs. 0 d.
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0.064, respectively).
Discussion
Detection of morphological damage in early cerebral
ischemia is difficult with conventional histological pro-
cedures including triphenyltetrazolium chloride and
hematoxylin-eosin staining. With these conventional
methods, morphological evidence of neuronal death
does not become apparent until 1 to 2 hours after the
onset of cerebral ischemia. However, early ischemic
lesions can now be detected by applying immunohisto-
chemical methods, and a reduction in microtubule-asso-
ciated protein 2 (MAP2) immunoreactivity has been
found to be an early, sensitive marker of ischemic neu-
ronal damage [6]. In our study, by using this method,
we showed that the lateral vestibular nucleus (LVe) and
the ventral part of the spinalt r i g e m i n a ln u c l e u s( v S p 5 )
were particularly vulnerable to ischemia.
In the LVe, multipolar giant neurons (Deiter’sn e u -
rons) were most vulnerable to ischemia. Vestibular neu-
rons receive excitatory glutaminergic input from the
vestibular nerve [7] and commissural excitatory afferents
[8]. Immunohistochemical and in situ hybridization his-
tochemical studies revealed the highest glutamate recep-
tor 2 (GluR2) expression in giant Deiter’sn e u r o n so f
the lateral vestibular nucleus and the lowest expression
in small neurons throughout the vestibular nuclei [9].
These reports suggest that Deiter’s neurons receive exci-
tatory input and have selective sensitivity to excitotoxi-
city. As an analogy to hippocampal neurons [10], we
speculate that an ischemia-induced alteration of GluR2
expression in Deiter’s neurons induced cell death.
Although further investigations are required to clarify
the mechanisms underlying this selective vulnerability
and delayed neuronal damage, they may also be related
to several other factors such as the degree of cerebral
hypoperfusion after reperfusion [11], inhibition of pro-
tein synthesis [12], neutrophil infiltration following
reperfusion [13], free radical production [14], dysfunc-
tion of the mitochondrial shuttle system [15] or apopto-
sis [16].
Furthermore, we showed that the ischemic lesions in
LVe and vSp5 had disappeared one day after reperfu-
sion, but appeared again three days after reperfusion
and thereafter. The observed loss of immunoreaction for
MAP2 may reflect cytoskeletal breakdown, because
MAP2 is involved in maintaining the structural integrity
of the neuronal cytoskeleton [17]. The ischemia-induced
rapid elevation of intracellular Ca
2+ concentration and
subsequent activation of Ca
2+-dependent phosphatases
(e.g., calcineurin) and proteases (e.g., calpains) can lead
to dephosphorylation and proteolytic degradation of
MAP2 [18,19]. Therefore, ischemia-induced loss of
immunoreaction for MAP2 is considered to be a reliable
marker of neurons that are already undergoing irreversi-
ble processes in cell death [20]. However, Kitagawa et al.
showed that loss of MAP2 immunostaining preceded
the development of overt neuronal loss in a gerbil
model of transient forebrain ischemia [6]. Our results
are also consistent with this notion that MAP2 immu-
nostaining can be used as an indicator of still viable
neurons that will undergo irreversible injury only at a
later time point.
We also demonstrated clusters of IBA-1-expressing
cells in the ischemic lesions where MAP2 staining was
lost three days after ischemia and thereafter. The rat
Iba1 gene has been identified as a microglia-specific
transcript [21]. The isolated Iba1clone was 0.8 kb, a
rather small cDNA encoding a 17-kDa protein consist-
ing of 147 amino acids. IBA-1 is an interferon-g (IFN-
g)-inducible Ca
2+-binding EF-hand protein that is
encoded within the HLA class III genomic region.
Expression of IBA-1 is mostly limited to the monocyte/
macrophage lineage, and is augmented by cytokines
such as IFN-g. It was assumed that IBA-1 is a novel
molecule involved in inflammatory responses and allo-
graft rejection, as well as activation of macrophages [22].
In the normal brain, IBA-1 is highly expressed in resi-
dent microglial cells, but is never expressed in neurons
and astrocytes [22]. After ischemia, IBA-1 is also
expressed in activated resident microglial cells and infil-
trating hematogenous macrophages [23,24].
Resident microglial cells rapidly became activated after
ischemia. They developed amoeboid or rounded cell
bodies and migrated rapidly into the ischemic lesion.
For example, IBA-1 expression was rapidly up-regulated
in the gerbil hippocampal CA1 region at 30 min after
transient forebrain ischemia for 5 min [25]. However,
microglial cells did not proliferate rapidly. Denes et al.
showed that resident microglial cells exhibited intense
proliferation at 48 and 72 h after transient occlusion of
the middle cerebral artery (MCA) in the mouse. Average
microglial cell number in the ischemic lesion did not
increase significantly up to 48 h after transient ischemia
[26]. We also demonstrated that a significant increase in
Iba-1-positive cells was not detected in the ischemic
cortex of the rat until one day after permanent MCA
occlusion (MCAO), while a significant decrease in Iba-
1-positive cells was detected even 2 h after permanent
MCAO[27]. Furthermore, infiltrating hematogenous
macrophages do not appear in the brain within one day
after ischemia [24]. In this study, we did not detect clus-
ters of IBA-1-expressing cells (i.e. topical proliferation of
microglial cells) within one day after ischemia. Clusters
of IBA-1-expressing cells initially appeared in the core
of the ischemic lesions three days after ischemia, and
these IBA-1-positive cells exhibited round cell bodies
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cesses, indicating a motile phagocytic phenotype. At
seven days after ischemia, IBA-1-expressing cells with
an amoeboid shape were distributed more peripherally
in the ischemic lesions as well as in the core of the
ischemic lesions. Based on their morphological features
and the temporal profile of the distribution of IBA-1-
positive cells in ischemic lesions, we speculated that
these IBA-1-expressing cells were of hematopoietic ori-
gin, although we could not exclude the possibility that
they were of resident microglial origin.
In addition, we showed that delayed progression of
ischemic neural death took place in the brainstem.
Although other morphological and biochemical investi-
gations including electron microscopic study are
required for further analysis, this delayed neuronal
damage in the brainstem is reminiscent of the delayed
neuronal death in the hippocampus after transient fore-
brain ischemia [5]. There is increasing evidence that
microglial cells contribute to delayed neuronal death.
Recruitment and activation of microglial cells gradually
increase within the hippocampal CA1 area over 24 h
after transient forebrain ischemia, before the degenera-
tion of neurons [28]. Endangered neurons can release
proinflammatory chemokines such as monocyte che-
moattractant protein-1 (MCP-1/CCL2) and secondary
lymphoid-tissue chemokine (SLC/CCL21). Expression of
MCP-1 and SLC is increased in neurons after ischemia
[29,30]. Subsequently, recruited and activated microglial
cells produce inflammatory mediators, including inter-
leukin-1b (IL-1b), tumor necrosis factor-a (TNF-a), and
nitric oxide (NO), which contribute to delayed neuronal
death [31]. Moreover, immunosuppressants, such as
FK506, prevent microglial activation and neuronal
damage after ischemia [32]. Consistent with these find-
ings, our results also suggest that activated microglia/
macrophages play a crucial role in this delayed neuronal
cell death in the brainstem.
Conclusions
In conclusion, we evaluated the evolution of ischemic
lesions in the brainstem after transient brainstem
ischemia in gerbils. Using immunostaining for MAP2,
ischemic lesions were detected in LVe and vSp5 in all
four animals. These ischemic lesions disappeared one
day after reperfusion, but appeared again three days
after reperfusion and thereafter in all animals exam-
ined. In addition, clusters of activated microglia/
macrophages were detected in these ischemic lesions
three days after ischemia and thereafter. These results
suggest that delayed neuronal cell death took place in
the brainstem after transient brainstem ischemia in
gerbils.
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